Skip to main content
SpringerLink
Log in

Cosmetovigilance

The ‘Beautiful’ Risk

  • Conference Paper
  • Published:
Drug Safety Aims and scope Submit manuscript

Abstract

A cosmetic is classically defined as any preparation that is applied to the skin, eyes, mouth, hair or nails for the purpose of cleansing, enhancing appearance, giving a pleasant smell or giving protection. Unlike drugs, which are used to treat or prevent a disease in the body, cosmetics are not thought to change or affect the body’s structure or functions. However, the distinction between drugs and cosmetics is sometimes not clear.

Regulations for cosmetic products primarily address the safety of products that may be used by large populations of healthy consumers. However, the efficacy and safety of cosmetic products are not reviewed or approved by national authorities before they are sold to the public.

The identification and analysis of adverse effects related to cosmetic products is a process that is currently still, to a large extent, industry driven. It is the responsibility of manufacturers to determine that products and ingredients are safe before they are marketed, and then to collect reports of adverse reactions. However, although the manufacturers do their best to monitor the safety profile of their products, we should consider that there is always a potential inherent conflict of interest.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. EU Cosmetics directive 76/768/EEC art.1

  2. Federal Food, Drug, and Cosmetic Act. Chapter II, section 201

  3. Ly F, Soko AS, Dione DA, et al. Aesthetic problems associated with the cosmetic use of bleaching products. Int J Dermatol 2007 Oct; 46 Suppl. 1: 15–7

    Article  PubMed  Google Scholar 

  4. Rguibi M, Belahsen R. Fattening practices among Moroccan Saharawi women. East Mediterr Health J 2006 Sep; 12 (5): 619–24

    PubMed  CAS  Google Scholar 

  5. Johansen JD. Fragrance contact allergy: a clinical review. Am J Clin Dermatol 2003; 4 (11): 789–98

    Article  PubMed  Google Scholar 

  6. Mehta SS, Reddy BS. Cosmetic dermatitis: current perspectives. Int J Dermatol 2003; 42 (7): 533–42

    Article  PubMed  Google Scholar 

  7. Council of Europe. The Council of Europe recommends a vigilance system for undesirable effects of cosmetic products (“cosmetovigilance”) [online]. Available from URL: http://www.coe.int/t/dc/press/NoteRedac2006/20061109_cosme-tovigilance_en.asp[Accessed 2007 Dec 12]

Download references

Acknowledgements

No sources of funding were used to assist in the preparation of this conference paper. The authors have no conflicts of interest that are directly relevant to the content of this conference paper.

Author information

Authors and Affiliations

  1. Clinical Pharmacology Unit, University of Verona, Policlinico GB Rossi, Piazzale LA Scuro, 37134, Verona, Italy

    Ugo Moretti & Giampaolo Velo

Authors
  1. Ugo Moretti
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Giampaolo Velo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ugo Moretti.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Moretti, U., Velo, G. Cosmetovigilance. Drug-Safety 31, 437–439 (2008). https://doi.org/10.2165/00002018-200831050-00011

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002018-200831050-00011

Keywords

Search

Navigation